Cargando…
Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
AIMS: Atrial fibrillation (AF) ablation is generally performed after patients fail antiarrhythmic drug (AAD) therapy. Some patients have drug contraindications or choose to avoid a lifetime of drug therapy. Little is known about the impact of previous drug therapy on ablation outcomes. We evaluated...
Autores principales: | Winkle, Roger A., Mead, R. Hardwin, Engel, Gregory, Kong, Melissa H., Patrawala, Rob A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051413/ https://www.ncbi.nlm.nih.gov/pubmed/22310154 http://dx.doi.org/10.1093/europace/eur370 |
Ejemplares similares
-
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
por: Winkle, Roger A., et al.
Publicado: (2013) -
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014) -
Comparison of CHADS(2) and CHA(2)DS(2)-VAS(C) anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients
por: Winkle, Roger A., et al.
Publicado: (2014) -
Trends in atrial fibrillation ablation: have we maximized the current paradigms?
por: Winkle, Roger A., et al.
Publicado: (2012) -
Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2013)